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Following a single episode of acute
gastrointestinal infection, microbiota-
dependent inflammation of the
mesenteric adipose tissue and damage to
the lymphatic system disrupt the
communication between the immune
system and the tissue, causing an
‘‘immunological scar’’ that compromises
tissue immunity and homeostasis in the
long term.
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Infections have been proposed as initiating factors
for inflammatory disorders; however, identifying as-
sociations between defined infectious agents and
the initiation of chronic disease has remained
elusive. Here, we report that a single acute infection
can have dramatic and long-term consequences for
tissue-specific immunity. Following clearance of
Yersinia pseudotuberculosis, sustained inflamma-
tion and associated lymphatic leakage in the
mesenteric adipose tissue deviates migratory den-
dritic cells to the adipose compartment, thereby
preventing their accumulation in the mesenteric
lymph node. As a consequence, canonical mucosal
immune functions, including tolerance and protec-
tive immunity, are persistently compromised.
Post-resolution of infection, signals derived from
the microbiota maintain inflammatory mesentery
remodeling and consequently, transient ablation
of the microbiota restores mucosal immunity.
Our results indicate that persistent disruption of
communication between tissues and the immune
system following clearance of an acute infection
represents an inflection point beyond which tissue
homeostasis and immunity is compromised for
the long-term.354 Cell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc.INTRODUCTION
The immune system deals with highly diverse infectious chal-
lenges in a manner that both promotes the control of invading
agents and restores tissue homeostasis. At barrier tissues, the
sites of constitutivemicrobial exposure, tissue-specific immunity
requires defined structural components that provide spatial
segregation from the microbiota to ensure maintenance of organ
function and enable the balance between tolerance to environ-
mental antigens and regulated protective immunity (Mowat and
Agace, 2014). These balanced processes are essential for the
preservation of tissue integrity. Inflammatory diseases affecting
barrier sites develop as a result of a breakdown in tissue homeo-
stasis and the subsequent failure to regulate immune responses
to environmental or microbial antigens (Belkaid and Segre, 2014;
Maloy and Powrie, 2011).
Acute infections represent frequent and violent tissue pertur-
bations from which the immune system must rapidly rebound.
It is estimated that >70% of all people in the United States expe-
rience a respiratory tract infection each year, and the average
child will suffer ten diarrheal episodes before the age of 5, a num-
ber that is dramatically higher in low to middle income countries
(Fendrick et al., 2003; Kosek et al., 2003; Vernacchio et al., 2006).
At barrier sites in particular, acute infections represent highly
volatile situations, with pathogens, commensals, and environ-
mental antigens transiently sharing the same inflamed environ-
ment. As a consequence, in the gastrointestinal (GI) tract, acute
mucosal infections are characterized by dysbiosis associated
with significant shifts in the microbiota and dominance of
bacteria with enhanced invasive capabilities and other proper-
ties that can directly exacerbate inflammation and tissue dam-
age (Belkaid and Hand, 2014). Because regulatory responses
are often transiently neutralized during acute infection, these
encounters can also blur the distinction between benign constit-
uents and pathogenic organisms (DePaolo et al., 2011; Hand
et al., 2012; Oldenhove et al., 2009). What remains unclear is
whether acute infections produce persistent changes that nega-
tively impact immune function, and if so, what are the mecha-
nisms of such effects?
These questions are especially compelling in light of the
rising incidence of inflammatory disorders, particularly involving
those diseases affecting barrier tissues such as inflammatory
bowel disease, psoriasis, allergy, and asthma (Molodecky
et al., 2012; Salgame et al., 2013). A number of environmental
stressors, including infections have been invoked as possible
triggers. Chronic infections in particular can have significant
bystander consequences on the capacity of the host to respond
to subsequent challenges (Barton et al., 2007; Cadwell et al.,
2010; Jamieson et al., 2013; Osborne et al., 2014; Salgame
et al., 2013). However, identifying direct associations between
defined infectious agents and the initiation of chronic disease
has remained difficult. One possible explanation for this difficulty
in establishing cause-effect relationships could be that infections
associated with the breakdown of tissue homeostasis may not
be temporally coincident with the eruption of symptomatic dis-
ease, and previously cleared infections could have long-term
and cumulative effects on the immune system.
Here, we show that a single transient encounter with a GI
pathogen, Yersinia pseudotuberculosis, can have dramatic
and persistent consequences on tissue-specific immunity.
Infection-induced remodeling of the mesentery and increased
leakage of lymphatic vessels persistently interrupts the immune
dialog between the gut and associated lymphoid tissue. These
sequelae of a cured infection interfere with the capacity of the
host to develop both tolerance and adaptive immunity to oral
antigens and are sustained by the microbiota. Thus, in defined
infectious settings, the immune system can reach an inflection
point beyondwhich restoration of tissue homeostasis and immu-
nity requires intervention. These results reveal that acute infec-
tions could impose ‘‘immunological scarring’’ that may have
cumulative and long-term consequences. This work provides a
framework for understanding how previously experienced infec-
tious stressors that are no longer present in the host can cause
localized immune damage that may contribute to the breakdown
of tissue-specific immunity and the emergence of complex
diseases.
RESULTS
Oral Infection with Yersinia pseudotuberculosis Induces
Chronic Mesenteric Lymphadenopathy
Yersinia pseudotuberculosis is a foodborne Gram-negative bac-
terium that, in humans, can cause a range of GI syndromes from
acute enteritis tomesenteric lymphadenitis and pseudoappendi-
citis (Asano, 2012; Wren, 2003). In mice, oral infection with 107
colony-forming units (CFU) of Y. pseudotuberculosis (IP32777)
caused a transient infection, with the peak of bacterial burdenat day 7 post-infection (Figure 1A) (McPhee et al., 2012; Simonet
and Falkow, 1992). As previously described (Fahlgren et al.,
2014), systemic control of the infection was achieved by 3 weeks
post-infection in most animals (Figures 1A and S1A). T cell re-
sponses are important for the control of Y. pseudotuberculosis
infection (Bergman et al., 2009; Bergsbaken and Bevan, 2015;
Zhang et al., 2012) and the number of IFN-g-producing anti-
gen-specific (YopE69–77) CD8
+ T cells increased significantly
by 2 weeks post-infection before contracting, in concert with
clearance of the bacteria (Figures S1B and S1C).
Concurrent with the peak of bacterial burden,
Y. pseudotuberculosis induced a rapid influx of neutrophils and
monocytes into all infected tissues (Figures 1B–1D and data not
shown). This increase in phagocytic cells largely subsides in all
compartments, except for the MLN (Figures 1B–1D and data
not shown). Despite efficient control of the bacteria, a significant
fraction of infected mice (70%) developed chronic mesenteric
lymphadenopathy (CL+) defined by 3- to 4-fold tissue enlarge-
ment, the formation of central abscesses, the presence of foamy
macrophages, and significant collagen deposition (Figures 1E–
1H and S1D). All of these features are reminiscent of the MLN
pathology that can be observed during human infections with
Y. pseudotuberculosis (Asano, 2012). Lymphadenopathy was
highly restricted to the MLN and still detectable 9 months post-
resolution of the infection (Figures 1E and 1I). This response
was not associated with persistent infection of the gut, MLN,
andmesenteric adipose tissue (MAT) (Figures 1A andS1A). How-
ever, CL+ lymph nodeswere not sterile and bacteria (the vastma-
jority belonging to the genus Lactobacillus) could be grown post-
resolution of the infection (Figures S1E and S1F). Thus, acute
infection with Y. pseudotuberculosis can induce long-term and
localized damage to gut-associated lymphoid structures.
Impaired Tissue-Specific Adaptive Immunity Post
Y. pseudotuberculosis Infection
The profound disruption of MLN structure following
Y. pseudotuberculosis infection led us to explore the possibility
that the homeostatic immune dialog between mucosal antigens
and the gut-associated secondary lymphoid tissue may be
compromised. To address this point, we first explored the poten-
tial impact of lymphoid tissue remodeling following infection on
the acquisition of oral tolerance, a process that is largely regu-
lated by the induction of antigen-specific peripheral Treg cells
(pTreg) (Coombes et al., 2007; Hadis et al., 2011; Sun et al.,
2007). To this end, T cells from Rag1/ OT-II TCR-transgenic
mice were transferred into mice fed with ovalbumin (OVA). Con-
trols included naive hosts as well as mice that controlled
Y. pseudotuberculosis without developing lymphadenopathy
(CL). In naive OVA-fed mice, a significant fraction of OT-II cells
accumulating in the GALT expressed Foxp3 (Figures 2A and 2B).
Furthermore, >30% of pTreg cells co-expressed GATA3 (Fig-
ure 2A), a transcription factor associated with Treg fitness
(Wang et al., 2011; Wohlfert et al., 2011). In contrast, pTreg gen-
eration was significantly impaired in mice harboring enlarged
MLNs (CL+) compared to naive or CL mice (Figures 2A and
2B). The percentage of Treg cells expressing GATA3 was also
significantly decreased in CL+ compared to control mice (Figures
2A and 2B). Acquisition of tolerance to orally fed antigens can beCell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc. 355
Figure 1. Oral Infection with Y. pseudotuberculosis Induces Persistent Mesenteric Lymphadenopathy
C57BL/6 mice were orally infected with Y. pseudotuberculosis (YP).
(A) Infectious burden in the spleen, MLN, and liver at indicated time points.
(B and C) Numbers of neutrophils and inflammatory monocytes from siLP, spleen, liver, and MLN.
(D) Representative flow cytometric contour plots indicating the percentage of neutrophils in the MLNs of naive and infected mice.
(E) Images on the left depict the gastrointestinal tract, mesenteric adipose tissue (MAT), and MLN (dotted lines) from naive and infected mice. Images on the right
show (from top) the axillary, brachial, lumbar, inguinal, and mesenteric lymph nodes.
(F) Weight of MLN from naive (white circles) or infected mice with chronic lymphadenopathy (CL+) (black circles) and without lymphadenopathy (CL) (gray
circles).
(G) Compilation of 15 separate experiments involving week 4 to week 9 infected mice showing the percent of animals with lymphadenopathy.
(H) Histology of naive and CL+ MLNs stained with picrosirius red. Large arrows show abscesses, arrowheads indicate areas of collagen deposition.
(I) Number of neutrophils in theMLN at day 300 post-infection. All bar graphs show themean ±SEM. All data shown, except (I) and (G), is representative of three to
six experiments, each containing three to five naive and six to ten infected animals. Data represented in (I) are representative of 2 experiments with three naive and
three to nine infected animals. *p < 0.05, **p < 0.005 compared to naive mice (Student’s t test).
See also Figure S1.measured by assessing immune responses following challenge
at peripheral sites (Curotto de Lafaille et al., 2008; Weiner
et al., 2011; Worbs et al., 2006). In contrast to naive mice, CL+
mice fed with OVA failed to acquire oral tolerance and developed
a delayed type hypersensitivity response to OVA challenge (Fig-
ure 2C). Thus, mesenteric lymphadenopathy induced by infec-
tion is associated with impaired acquisition of oral tolerance to
food antigens.
We next assessed whether lymphadenopathy could poten-
tially interfere with the induction of mucosal effector responses.356 Cell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc.To this end, we utilized a model of oral vaccination combining
a mixture of OVA and an attenuated double mutant of the
heat-labile enterotoxin of enterotoxigenic Escherichia coli (LT
R192G/L211A; hereafter referred to as dmLT) (Hall et al.,
2008). As previously shown, this regimen induces robust OVA
and dmLT-specific Th17 cells (Hall et al., 2008) (Figures 2D
and 2E). The induction of Th17 cells specific for dmLT or
OVA was dramatically impaired in CL+ mice compared to
controls (Figures 2D and 2E). Induction of dmLT-specific and
OVA-specific IgA was also significantly reduced in CL+ mice
Figure 2. Infection-Induced Mesenteric Lymphadenopathy Is Associated with Disruption of Mucosal Immunity
(A and B) Naive or 4-week infected C57BL/6 (CD45.2) mice were transferred with CD45.1+ Rag1/ OT-II TCR transgenic T cells (CD45.1), fed ovalbumin
(OVA) in the drinking water, and cells from the siLP and MLNs were isolated. (A) Representative flow cytometric contour plots of Foxp3 and GATA3 expression
by OT-II T cells isolated from the siLP of naive and infected mice with or without lymphadenopathy (YP CL+ and YP CL, respectively). Numbers represent
the mean percentage within the gate (±SEM) of all samples in this experiment. (B) Numbers of OTII Foxp3+ and OT-II Foxp3+GATA3+ T cells in the siLP
and MLN.
(C) Top: scheme for induction of oral tolerance. CFA, complete Freund’s adjuvant. Bottom: footpad swelling was measured in the feet of sensitized mice after
challenge with OVA.
(D–F) Naive, YP CL and YP CL+ mice were immunized orally with OVA and double mutant heat labile toxin (dmLT). (D and E) Seven days after immunization,
lymphocytes were isolated from the siLP and stimulated in vitro with DCs pulsed with dmLT or OVA to measure T cell responses. (D) Flow cytometric
contour plots show representative populations of antigen-specific IFN-g and IL-17A-producing CD4+ T cells from naive, vaccinated (Ctrl/Vax), or
Y. pseudotuberculosis-infected vaccinated (YP CL+//Vax) mice. Numbers in plots represent the mean frequency of cells within the adjacent gate (±SEM) of all
samples within this experiment. (E) Numbers of IL-17A-producing CD4+ T cells from (D). (F) Measurement of dmLT and OVA-specific fecal IgA by ELISA. OD,
optical density.
(legend continued on next page)
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compared to vaccinated controls (Figure 2F). Infection with
Y. pseudotuberculosis also modestly modifies the fecal and
small intestinal composition of the microbiota (Figures 2G and
2H). Of note, no differences were found between CL+ versus
CL mice (Figure 2H).
Together, these results reveal that a single acute infection can
chronically alter the ability of the immune system to develop ca-
nonical mucosal responses necessary for maintenance of gut
immune homeostasis.
Chronic Mesenteric Lymphadenopathy Is Associated
with Defects in Dendritic Cell Migration
Effective activity of the mucosal immune system relies upon effi-
cient trafficking of DCs to the MLN to ensure the maintenance of
homeostasis with respect to antigens acquired from the intesti-
nal lumen (Hooper and Macpherson, 2010). We first examined
the spatial organization of the MLN following infection with
Y. pseudotuberculosis. Consistent with flow cytometry analysis
(Figures 1B–1D), confocal imaging revealed a significant accu-
mulation of LysM-eGFP+ cells at the center of the MLN (Fig-
ure 3A). The central T cell zone was displaced and distributed
in a disorganizedmanner at the periphery of theMLN of CL+ (Fig-
ures 3A and S2A). Additionally, B cell follicles and lymphatic ves-
sels that, in naivemice, localize at the periphery of theMLN, were
located at the edge of the abscess (Figure 3A). Naive T cells were
still present in the MLN post-infection, suggesting that some
MLN functions, such as the trafficking of lymphocytes from the
blood, may have been preserved (Figure S2B).
In thegut, immunedialog ismediatedby threemainantigenpre-
senting cells that can be segregated based on their expression of
integrin aE (CD103) and aM (CD11b) (Figure S2C) (Bekiaris et al.,
2014; Bogunovic et al., 2009; Grainger et al., 2014). In particular,
the migratory CD103-expressing DC subsets have been associ-
ated with the induction of Th17 and Treg cells (Coombes et al.,
2007; Satpathy et al., 2013; Schlitzer et al., 2013; Schulz et al.,
2009;Sunet al., 2007; Varol et al., 2009). The frequency andabso-
lute number of migratory CD103+CD11b+ DCs were dramatically
reduced in theMLNofCL+mice compared to naive andCLmice
(Figures 3B and 3C). CD103+CD11b DCs in the MLN were also
reduced, albeit to a lesser degree (Figures 3B and 3C). For the
remainder of this study, we focused on the migratory
CD103+CD11b+ DC subset, whose unique phenotype allows for
faithful tracking during inflammation. Importantly, the defect in
CD103+CD11b+ DCs was restricted to the MLN as gut lamina
propria DC subsets were unchanged in CL+ mice versus controls
(Figure 3D). These results support the idea that lack of migratory
CD103+CD11b+ DCs in the MLN was not the consequence of a
defect inDCdevelopmentorguthoming,but the result of impaired
migration and/or accumulation in the MLN.
Extraction of cells from the MLNs of CL+ mice could be biased
because of the high level of collagen deposition (Figure 1H).
Histo-cytometry allows for the identification, spatial positioning,(G) Bar graphs showing the fraction of the fecal microbiota represented by ind
sequencing at the time points indicated.
(H) Principal coordinate analysis of 16S gene sequencing data derived from fecal a
(H), are representative of three to five separate experiments containing five contro
*p < 0.05, **p < 0.005, ***p < 0.0005 (Student’s t test).
358 Cell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc.and quantitative measurement of cells within their host tissue
(Gerner et al., 2012). Because CD103 is highly sensitive to fixa-
tion, we devised an alternative gating strategy to identify
CD103+CD11b+ DCs by histo-cytometry (Figures S3A and
S3B) (Merad et al., 2013). As previously described (Gerner
et al., 2012; Kissenpfennig et al., 2005), migratory and resident
DC subsets localized in distinct regions of naive LNs (Figures
3E, 3G, and S3C). This approach allowed us to describe the
localization of the migratory CD103+CD11b+ DCs in the MLN
under steady-state conditions as positioned peripheral to
CD103+CD11b DCs on the edge of the putative T cell zone
and in close proximity to the B cell follicles (Figures 3E and
3G). Following infection, the CD103+CD11b+ DCs were virtually
absent from CL+ MLNs compared to controls (Figures 3E–3G,
S3C, and S3D). The distribution of other DC subsets was not
altered (Figures 3E, S3C, and S3D). Thus, two complementary
approaches revealed a sustained defect in the accumulation of
migratory DCs in the MLN post-infection.
Acute Infection Alters Lymphatic Integrity and
Mesenteric Adipose Tissue Homeostasis
Notwithstanding the direct infection-related structural disruption
of the MLN, our results thus far support the idea that impaired
mucosal immunity following infection may be a consequence of
a selective defect in the capacity of migratory DCs to access the
MLN. In addition to cell trafficking, the gut-associated lymphatic
system is also responsible for the transport of lipids.Weassessed
the physical integrity of gut-draining lymphatic vessels by orally
administering the fluorescent long-chain fatty acid, Bodipy FL
C16 (Khalifeh-Soltani et al., 2014; Randolph and Miller, 2014). In
contrast to control mice, Bodipy FLC16 leaked into the surround-
ingmesenteric adipose tissue (MAT) of CL+mice, revealing ama-
jor defect in lymphatic containment, a defect that was sustained
up to 10 months post-infection (Figures 4A and S4A).
We next assessed how the loss of lymphatic integrity could
impact MAT immune homeostasis. Imaging of the MAT revealed
a massive infiltrate of hematopoietic cells in CL+, but not CL
mice (Figure 4B). This infiltrate was associated with a significant
increase in neutrophils and macrophages while the number of
type 2 immune cells including eosinophils and ILC2s, was signif-
icantly reduced (Figure 4C). TheMATshifted toward type1 immu-
nity, with a significant increase in the transcription of inflamma-
tory mediators, including, Ifng, Il1a, Il1b, Tnfa, Il12, Fpr1, Fpr2,
antimicrobial molecules, and chemokines (Figures 4D and S4B;
Table S1). Alteration of lymphatic integrity was not unique to
Y. pseudotuberculosis, as is demonstrated by leakage in models
of T cell transfer colitis and Toxoplasma gondii infection (Figures
S4C and S4D).
At steady state, the MAT contains CD103+CD11b and
CD103CD11b+ DCs, while CD103+CD11b+ DCs are largely
absent from this compartment (Figures 5A, 5B, and S4E). In
contrast, the frequency and number of CD103+CD11b+ DCsividual operational taxonomic units (OTUs) identified by 16S bacterial gene
nd small intestinal samples (weighted UniFrac). All experiments, except (G) and
l mice and five to ten infectedmice per group. All graphs show themean ± SEM.
Figure 3. Mesenteric Lymphadenopathy Is Associated with a Reduction in Migratory DCs in the MLN
(A) LysM-eGFP reporter mice were infected with Y. pseudotuberculosis. At 4 weeks post-infection, sections of naive or CL+ MLNs were analyzed by confocal
microscopy.
(B–D) Bar graphs show the numbers of each DC subset (gated as described in Figure S2C), isolated from theMLN (B) and siLP (D) at the time points indicated. (C)
Representative flow cytometric contour plots of DC subsets from the MLN and siLP. Numbers in plot represent the mean frequency of cells within the adjacent
gate (±SEM) of all samples within this experiment.
(E–G) MLN sections from naive or 4-week infected CX3CR1-GFP reporter mice were stained for analysis by multiparameter confocal microscopy. (E) Three-
dimensional ‘‘Cell-of-Interest’’ surfaces were generated based on CD11c expression and quantitatively analyzed by histo-cytometry (Figure S3) to identify the X
and Y positions of individual cells within the antigen-presenting cell subsets (labels below image). (F) Representative histograms obtained from the histo-
cytometric analysis indicating the expression of CD11b+ in cells occupying the CD11c+MHC IIhigh CX3CR1
CD64 gate (Figure S3). (G) Representative confocal
image of MLN sections stained for Collagen IV and CD8a overlaid with the position of CD11c+ MHC IIhigh CX3CR1
 CD64 CD11b+ DCs (analogous to
CD11b+CD103+ DCs) reconstructed by histo-cytometry. Dotted blue lines represent the B cell zones and red lines indicate the T cell zones. Images in (A), (E), and
(G) are representative of two separate experiments. Flow cytometry data from (B)–(D) are representative of five experiments each containing five control animals
and five to ten infected animals. All bar graphs show the mean ± (SEM). *p < 0.05, **p < 0.005, ***p < 0.0005 (Student’s t test). CL+, infected mice with
lymphadenopathy; CL, infected mice without lymphadenopathy.
See also Figures S2 and S3.
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Figure 4. Yersinia pseudotuberculosis Infection Is Associated with Lymphatic Leakage and Mesenteric Adipose Tissue Remodeling
(A) Naive or 4-week infected mice were gavaged with Bodipy FL C16. Shown are representative fluorescent microscope images of the MAT (top) or high-
magnification confocal images of individual MAT lymphatics overlaid with the bright field (bottom).
(B) MAT samples from naive or infected CX3CR1-GFP mice were stained and imaged by confocal microscopy.
(C) Numbers of ILC2s, eosinophils, neutrophils, and macrophages in the MAT determined by flow cytometry.
(D) Heat map of gene expression from CD45+ cells isolated from the MAT at the indicated time points and analyzed by NanoString technology. Images in (A) and
(B) are representative of three experiments. Data from (C) are representative of three to five experiments each containing five control animals and five to ten
infected animals. Data in (D) are representative of two separate experiments. All bar graphs show themean (±SEM). *p < 0.05, **p < 0.005, ***p < 0.0005 (Student’s
t test). CL+, infected mice with lymphadenopathy; CL, infected mice without lymphadenopathy.
See also Figure S4 and Table S1.dramatically increased in the MAT post-infection, an effect that
persisted for at least 10 months post-infection (Figures 5A and
5B).We next examinedwhethermigratory DCs had extravasated
into the adipose tissue by confocal microscopy. While, in control360 Cell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc.mice fewCD11c+ and/or CD11b+ cells resided in the adipose tis-
sue, in CL+ mice, antigen-presenting cells accumulated in the
MAT particularly in areas surrounding the lymphatic vessels (Fig-
ures 5C, 5D, and S4F). These results support the idea that
Figure 5. CD103+CD11b+ DCs Accumulate
in the MAT following Infection with Yersinia
pseudotuberculosis
(A) DC subsets in the MAT as characterized by
flow cytometry, according to the gate strategy
described in Figure S4E. Shown are representative
contour plots of MAT DC subsets from naive or
infected animals (CL+/). Numbers in plot indicate
the mean frequency of cells (±SEM) within the
adjacent gate from all samples in this experiment.
Bar graph shows the number of CD103+CD11b+
DCs in the MAT.
(B) Bar graphs show the frequency and number
of CD103+CD11b+ DCs in the MAT at 42 weeks
post-infection.
(C) Representative whole tissue fluorescent im-
ages of MAT from naive or 4-week infected
CD11c-YFP reporter mice.
(D) Representative confocal images describing
the localization of CD11c+CD11b+MHC II+ cells in
relation to lymphatics (LYVE1+) in the MAT. All the
data are representative of three experiments each
containing five control animals and five to ten in-
fected animals. All bar graphs show the mean
(±SEM). *p < 0.05, ***p < 0.0005 (Student’s t test).
CL+, infected mice with lymphadenopathy; CL,
infected mice without lymphadenopathy.
See also Figure S4.following infection, migratory DCs prematurely escape the
lymphatic flow and are shunted to the adipose tissue.
Microbiota Sustains Impaired Tissue-Specific Immunity
following Infection
We next explored the possibility that the resident microbiota
might sustain tissue remodeling and inflammation following res-
olution of the infection. To address this possibility, we assessed
the consequences of Y. pseudotuberculosis infection in mice
devoid of live microbes (germ-free [GF]). Like specific path-
ogen-free (SPF) mice, GF mice cleared the bacteria from the
MLN, liver, and spleen, but, in contrast to SPF mice, not in the
GI tract (Figures S5A and S5B). This observation is consistent
with the known role for themicrobiota as an agent of colonization
resistance (Buffie and Pamer, 2013). GF mice still developed
lymphadenopathy, albeit to a lesser magnitude than in SPF
mice, revealing that the microbiota was not strictly required for
infection-induced remodeling of the MLN (Figure 6A). On the
other hand, Y. pseudotuberculosis had no impact on the
capacity of CD103+CD11b+ DCs to accumulate in the MLN of
GF mice, highlighting a central role for the microbiota in the in-
duction and/or maintenance of this specific sequela of infection
(Figure 6B).
We next evaluated whether a transient ablation of the micro-
biota in SPF mice could reduce MAT inflammation and restoreCell 163, 354–36mucosal immune function. Antibiotic
treatment significantly reduced type I
inflammation of the MAT, prevented the
aberrant accumulation of CD103+CD11b+
DCs in the MAT, and restored their phys-iological homing to theMLN (Figures 6C and 6D). However, while
MAT inflammation was reduced following antibiotic treatment,
lymphatic integrity was not fully restored (Figure S5C). Oral
gavage of such mice with microbial-derived products was suffi-
cient to restore cellular infiltration into theMAT, (Figures S5D and
S5E) suggesting that the effect may be mediated by enhanced
microbial exposure independent of any defined microbiota.
Indeed, mice developing lymphadenopathy can be found in the
same cage as CL mice (Figure S5F).
We next assessed if antibiotic treatment was sufficient to
restore mucosal immunity. As previously described, antibiotic
treatment reduced the efficacy of oral vaccination (Hall et al.,
2008) (Figures 6E and S5G). Nonetheless, a substantial number
of Th17 cells specific for dmLT or OVA were still induced and
accumulated in the lamina propria of vaccinated mice (Fig-
ure 6E). Together with restoration of MAT homeostasis, antibi-
otic treatment also restored the capacity of CL+ mice to respond
to oral vaccination to a level comparable to naive antibiotic-
treated mice (Figure 6E). Thus, damage induced by acute
infections may be reversible and limiting exposure to defined
microbial products while promoting lymphatic repair may
represent a therapeutic strategy to restore mucosal immunity.
Taken together, these data reveal a central role for the micro-
biota in the maintenance of the immune defects induced by
acute infection.6, October 8, 2015 ª2015 Elsevier Inc. 361
Figure 6. Microbiota Sustains MAT Inflammation and Immune Dysfunction Post-infection
(A and B) Specific pathogen-free (SPF) or germ-free (GF) C57BL/6 mice were infected with Y. pseudotuberculosis. (A) Sections of MLNs isolated 4 weeks post-
infection were stained with picrosirius red. (B) Frequency and number of DC subsets in the MLN. Shown are representative flow cytometric contour plots of DC
subsets (gated according to the Figure S2C). Numbers in plots represent the mean frequency (±SEM) of cells within the adjacent gate. Bar graph shows the
numbers of CD103+CD11b+ DCs in the MLN.
(C and D) Four weeks post-infection, SPF mice were treated with broad-spectrum antibiotics (Abx) for 3 weeks. (C) Bar graphs show the number of
CD103+CD11b+ DCs (gated as indicated in Figure S4E), neutrophils, and eosinophils isolated from the MAT of naive or infected animals with or without antibiotic
treatment. (D) Shown are representative plots of theMLNDC subsets from naive and infectedmice, with and without antibiotic treatment. Numbers represent the
mean frequency (±SEM) of cells within the adjacent gate of all samples within this experiment. Bar graph shows the number of CD103+CD11b+ DCs in the MLNs.
(E) Top: scheme for vaccination of antibiotic-treated mice. Abx treatment was continued during the vaccination period. 7 days post-immunization, lymphocytes
were isolated from the siLP and stimulated in vitro with dmLT or OVA pulsed DCs. Bottom left: contour plots showing IFN-g and IL-17A producing CD4+ T cells
after vaccination in naive (Ctrl Vax) or infected (YP Vax) mice treated with Abx. Numbers represent the percent of CD4+ T cells that express each cytokine in the
adjacent gate. The bar graph (bottom right) shows the mean percent of IL-17A producing CD4+ T cells from Abx treated naive or infected mice. All data are
representative of two to three experiments with three to five mice in each control group and five to seven mice in each infected group. All bar graphs show the
mean (±SEM). *p < 0.05, **p < 0.005, ***p < 0.0005 (Student’s t test). CL+, infectedmice with lymphadenopathy; CL, infectedmice without lymphadenopathy; ns,
not significant.
See also Figure S5.
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DISCUSSION
Here, we report that a single acute infection can lead to long-
lived ‘‘immunological scarring’’ with profound effects on tissue
immunity that persist after the pathogenic organism has been
cleared. Infections have long been considered as possible trig-
gering elements in the development of chronic inflammatory dis-
eases and immune dysfunction, but definitive and mechanistic
associations between defined pathogens and the breakdown
of tissue homeostasis have remained elusive. Our work provides
a mechanistic framework via which infection may represent
a point of no return for tissue immunity, leading to chronic
inflammation and immune dysfunction long after the pathogen
has been cleared.
In this study, we found that oral infection with
Y. pseudotuberculosis profoundly and persistently remodels
both the MAT and MLN. The pathological effect of infection in
this mouse model reproduces the chronic lymphadenopathy
that is a defining characteristic of Y. enterocolitica or
Y. pseudotuberculosis infection in humans (Asano, 2012).
Chronic mesenteric lymphadenopathy is not limited to Yersinia
infection, as a variety of other diseases can also cause these
symptoms, such as HIV/AIDS, Crohn’s disease, and celiac dis-
ease (Asano, 2012; Estes et al., 2008; Huppert et al., 2004; Lucey
et al., 2005). The mechanism by which Y. pseudotuberculosis
triggers damage to the lymphatic system is not understood,
but is possibly related to the fact that Yersinia and other patho-
gens drive phagocytic cells to travel through these vessels
(Bou Ghanem et al., 2012; Diehl et al., 2013; St John et al.,
2014). We also show that increased permeability of lymphatics
can be observed in other models of GI infection or non-infectious
colitis. As such, the point raised by our present work is not that
Y. pseudotuberculosis per se is responsible for the breakdown
of tissue immunity, but that in defined settings or in genetically
predisposed individuals, GI infections and/or inflammation,
may play a determinant role in the disruption of immune homeo-
stasis by remodeling the immune and lymphatic system.
Two cytokines, IL-1b and TNF-a, have been shown to increase
lymphatic permeability and both are significantly increased in the
MAT post-infection (Aldrich and Sevick-Muraca, 2013; Cromer
et al., 2014). Another potential contributing factor in chronic
inflammation of the MAT is the switch from type 2 to type 1 im-
munity. Because type 2 immunity has recently been described
as critical to tissue healing (Gause et al., 2013), persistent
lymphatic damage post-infection may also be the consequence
of a loss of these responses. There are a number of interesting
parallels between the chronic remodeling of the MAT seen after
Y. pseudotuberculosis infection and inflammatory bowel dis-
ease. Notably, inflammation of the MAT, altered lymph drainage
and presence of translocating commensals in this compartment
has been described in Crohn’s disease patients (Behr, 2010;
Peyrin-Biroulet et al., 2012; Zulian et al., 2013). In accordance
with these studies, we measured increased lymphatic leakage
in the T cell transfer model of colitis. Previous studies have
also shown that the larger, contractile lymphatics are permeable
to soluble antigens and that adipose tissue dendritic cells can
sample molecules traveling in the lymph (Kuan et al., 2015).
Furthermore, when permeability of lymphatic collecting vesselsis increased, the absorptive function of upstream lymphatic cap-
illaries, such as those in intestinal villi, is decreased (Scallan
et al., 2013) a phenomenon that could be relevant to our
present observation. Therefore, exploration of the involvement
of lymphatic damage and inflammation in the MAT could be
important to our understanding of the pathophysiology of
Crohn’s disease and gut inflammatory disorders in general.
Infection abrogated the accumulation of the migratory
CD103+CD11b+ DCs in the MLNs, a cardinal subset of gut
DCs involved in the promotion of both T and B cell responses,
(Bogunovic et al., 2009; Farache et al., 2013; Satpathy et al.,
2013; Schlitzer et al., 2013). We also observed a partial reduction
in the frequency of CD103+CD11b DCs in the MLN, a pop-
ulation associated with Treg induction (Coombes et al., 2007;
Sun et al., 2007). Because inflammation can complicate the
identification of these cells (Merad et al., 2013), migratory
CD103+CD11b DCs may be more profoundly affected by the
infection than reported here, a point supported by the substantial
impact of the infection on Treg induction. Of interest, infection-
induced disruption of the positioning of DCs and macrophages
in the LN has been observed in multiple settings of infection
and vaccination and similar defects due to lymphadenopathy
may further affect DC function in our model (Gaya et al., 2015;
Katakai et al., 2004; Mueller et al., 2007).
Immunological damage from acute infection had profound
consequences for the maintenance of tissue-specific immunity,
including defects in the development of Th17 cells, Treg, and IgA
+
B cell responses in the GI tract. Collectively, these responses
represent the canonical mucosal immune response required
for oral tolerance, adaptive immunity, and compartmentalization
of the microbiota (Belkaid and Hand, 2014). Our findings indicate
that under conditions in which the environment is in flux, some
acute infections may predispose to food allergy and aberrant im-
mune responses to commensals via the abrogation of Treg induc-
tion. In low to middle income countries, oral vaccines for Rota-
virus, Poliomyelitis, Vibrio cholerae, and Shigella often fail to
protect with the same degree of efficacy as in high-income coun-
tries (Levine, 2010). Several interrelated conditions, including
persistent infections, gut inflammation, malnutrition, and envi-
ronmental enteropathy, have been proposed to contribute to
this important public health issue (Korpe and Petri, 2012; Levine,
2010). Our observed defects in DC trafficking and the develop-
ment of Th17 and IgA responses to model oral vaccinations
may provide an explanation for the immune dysfunction in these
populations. Interestingly, when individuals suffering from envi-
ronmental enteropathy are relocated to Western countries,
where diet and sanitation are no longer issues, it can take up
to 2 years for intestinal absorption to be restored, implying that
the physiological defects outlive exposure to acute infections
(Lindenbaum et al., 1972). Based on our present work, we pro-
pose that the integrity of the MAT and lymphatics could be
also severely affected under these settings and that this phe-
nomenon may contribute to immune dysfunction.
The microbiota plays a central role in the maintenance of the
immunological damage caused by Y. pseudotuberculosis infec-
tion. This observation reveals yet another way by which interrup-
tion of the host’s relationship with its microbiota can compro-
mise tissue homeostasis. Our current model proposes thatCell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc. 363
such effects may not be associated with a defined microbiota.
Notably, mice developing lymphadenopathy do not have a
unique microbiota compared to those mice that did not develop
lymphadenopathy and oral gavage of definedmicrobial products
can phenocopy the effect of the microbiota. Thus, increased
exposure to microbes or microbe-derived ligands provided by
the increased leakage of the lymphatics may be sufficient to
induce a positive feedback loop of inflammation in the MAT, an
effect that could predispose to the development of inflammatory
disorders. On the other hand, we cannot exclude the possibility
that benignmicrobes such as lactobacilli that can be found in the
CL+ MLN could be contextually pathogenic post-infection.
The ‘‘hygiene hypothesis’’ proposes that increasing rates
of allergy and asthma in western countries could be the conse-
quence of reduced infectious disease, in particular helminthic
worm infection during early childhood (Johnston et al., 2014;
Schaub et al., 2006; Weinstock et al., 2004). More recently,
this model has been modified to include the modern shift in the
human microbiota (Blaser and Falkow, 2009). Together, these
profound changes inmicrobial encounters and, as a direct result,
the state of the immune system, are believed to contribute to
the dramatic increase in chronic inflammatory and autoimmune
disorders seen in high-income countries. Our present work
proposes that this model also needs to integrate the change in
the frequency and type of acute infections associated with
high-density urban living. Modern societies are now burdened
with endemic respiratory and GI infections, whose long-term
sequelae are not fully understood. These repeated and unregu-
lated inflammatory challenges may profoundly remodel the im-
mune system and thereby contribute to the increased burden
of autoimmune and inflammatory disorders.
Together, this study provides a framework to understand how
previously encountered infections can induce a breakdown of
tissue immune homeostasis, thereby contributing to disease
later in life. Thus, in order to fully comprehend the etiology of
complex diseases, it may be necessary to look beyond a pa-
tient’s genetic susceptibilities and concurrent environmental
stressors and examine whether immunological scarring asso-
ciated with previous infections may have ‘‘set the stage’’ for
chronic inflammation.EXPERIMENTAL PROCEDURES
Mice
C57BL/6NTac SPF mice were purchased from Taconic Farms. Germ-free
C57BL/6 mice were bred at Taconic Farms and maintained in the National
Institute of Allergy and Infectious Diseases (NIAID) gnotobiotic facility.
C57BL/6NTac-Lysozyme (Lyz2) (LysM-eGFP reporter), B6.SJL-Ptprca/
BoyAiTac (CD45.1), C57BL/6-[Tg]CD11c(Itgax):EYFP (CD11c-eYFP reporter),
B6.129P(Cg)-Ptprca Cx3cr1
tm1Litt/LittJ (CX3CR1 GFP reporter), and C57BL/
6-CD45a(Ly5a)-Rag1/ TCR OT-II (Rag1/ OT-II TCR transgenic) mice
were obtained through the NIAID-Taconic exchange program. All mice were
bred and maintained under pathogen-free conditions at an American Associ-
ation for the Accreditation of Laboratory Animal Care accredited animal facility
at the NIAID and housed in accordance with the procedures outlined in the
Guide for the Care and Use of Laboratory Animals. Gender- and age-matched
mice between 6–12 weeks old were used. When possible, preliminary exper-
iments were performed to determine requirements for sample size, taking into
account resources available and ethical, reductionist animal use. In general,
eachmouse of the different experimental groups is reported. Exclusion criteria364 Cell 163, 354–366, October 8, 2015 ª2015 Elsevier Inc.such as inadequate staining or low cell yield due to technical problems were
pre-determined.
Oral Infection, Vaccination, and Treatments
For infection, Y. pseudotuberculosis (strain IP32777) (Simonet and Falkow,
1992) was grown into 2XYT media (Quality Biological) overnight at 25C with
vigorous shaking. Mice were fasted for 12 hr prior to infection with 1 3 107
CFU via oral gavage. Oral vaccination with double mutant E. coli heat labile
toxin (R192G/L211A) (dmLT) (provided by J. Clements) was carried out as pre-
viously described (Hall et al., 2008). Mice received two immunizations (7 days
apart and response was assessed 7 days after). For broad-spectrum antibiotic
treatment, mice were treated as previously described (Hall et al., 2008).
Commensal-derived DNA/LPS gavage of antibiotic-treated mice was per-
formed as previously described (Hall et al., 2008), with the modification that
250 mg of commensal DNA and 250 mg of LPS (from E. coli; Sigma) were gav-
aged every other day for a week.
Analysis of Leaking in the MAT
Bodipy FL C16 (40 mg/mouse) (Life Technologies) mixedwithmilk cream (10%)
(100 ml) and olive oil (100 ml) was gavaged into mice and MAT tissue was
isolated for microscopy 3 hr later and analyzed by scanning fluorescent
microscopy (Leica M205 FA, motorized stereo microscope) and confocal
microscopy (Leica SP8).
Statistics
Data are presented as mean ± SEM. Group sizes were determined based on
the results of preliminary experiments. Mice were assigned at random to
groups. Mouse studies were not performed in a blinded fashion. Statistical
significance was determined with the two-tailed unpaired Student’s t test,
under the untested assumption of normality. Within each group there was an
estimate of variation, and the variance between groups was similar. All statis-
tical analysis was calculated using Prism software (GraphPad). Differences
were considered to be statistically significant when p < 0.05.
For more detailed information, please consult the Supplemental Experi-
mental Procedures.
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